SAINTE-FOY, QUEBEC--(Marketwire - May 29, 2008) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced its results for the first quarter ended March 31, 2008.
